6505--Diltiazem SA Capsules (AB3)

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAC PHARMACEUTICALS (36E797)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36E79726R0022

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The Department of Veterans Affairs (VA), through its NAC Pharmaceuticals office, has issued an award notice for the procurement of Diltiazem SA Capsules (AB3). This contract, identified by procurement number 36E79726R0022, falls under the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing. The notice remains active as of August 26, 2026, and is accessible via the SAM.gov portal. The primary purpose of this procurement is to secure a reliable supply of Diltiazem SA Capsules, a pharmaceutical product classified under Product Service Code 6505. These capsules are intended to support the VA’s ongoing commitment to providing essential medications to veterans, ensuring continuity of care and maintaining high standards of pharmaceutical quality. The scope of the contract encompasses the manufacturing and supply of Diltiazem SA Capsules (AB3), with the expectation that the awarded contractor will adhere to all applicable regulatory and quality standards for pharmaceutical preparations. The intended outcome is to maintain a consistent inventory of this medication, supporting the VA’s healthcare delivery objectives. Key requirements include compliance with the NAICS 325412 classification, which mandates that contractors possess capabilities in pharmaceutical preparation manufacturing. The contract is managed by the NAC Pharmaceuticals office, a federal entity within the Department of Veterans Affairs, ensuring oversight and alignment with federal procurement policies. The primary point of contact for this procurement is Christopher Carthron, who can be reached at [email protected] or by phone at (708) 786-4980. Contractors interested in further details or clarifications are encouraged to contact Mr. Carthron directly. This procurement is an award notice, indicating that the contract has already been granted. While specific set-aside requirements or special considerations are not detailed in the notice, the classification and federal oversight suggest adherence to standard government contracting protocols. Overall, this opportunity reflects the VA’s ongoing need for high-quality pharmaceutical products to support veteran healthcare. Contractors with expertise in pharmaceutical manufacturing and a proven track record in supplying similar products may find this contract aligns with their capabilities, particularly if they are interested in future opportunities with the Department of Veterans Affairs.